Tuberculosis Disease and Infection in US-Bound International Adoptees: 2016 to 2023. [PDF]
Liu Y +6 more
europepmc +1 more source
Scaling Up Tuberculosis Preventive Treatment: Progress and Factors Influencing Optimization - China, 2022-2025. [PDF]
Xu C, Li J, Wen Y, Hu D, Yu R, Zhao Y.
europepmc +1 more source
A Novel Therapy With a One-Month Ultrashort Regimen to Halt Progression From Latent Infection to Active Tuberculosis Among Close Contacts (The TB‑YOUTH Study): Protocol for a Cluster Randomized Controlled Trial. [PDF]
Yang Y +13 more
europepmc +1 more source
Positivity rate of QuantiFERON-TB Gold Plus<sup>®</sup> test among candidates for biotherapy and factors influencing results. [PDF]
Mezenner H +9 more
europepmc +1 more source
Detection for New Biomarkers of Tuberculosis Infection Activity Using Machine Learning Methods. [PDF]
Starshinova AA +15 more
europepmc +1 more source
The impact of frailty scores on latent tuberculosis infection and all-cause mortality in this population. [PDF]
Sun M, Fan J, Yang Y, Lin A.
europepmc +1 more source
Adalimumab Therapy for Crohn's Disease and Axial Spondyloarthritis in Latent Tuberculosis: <i>A bibliometric-systematic literature review</i>. [PDF]
Shofa NM +6 more
europepmc +1 more source
Detection of Latent Tuberculosis in Chronic Kidney Disease (CKD) Patients on Dialysis Using the Cy-TB Test: A Hospital-Based Cross-Sectional Study. [PDF]
Jagadeesan H +5 more
europepmc +1 more source
Common genetic determinants of dynamic human in vivo immune response to Mycobacterium tuberculosis
Zhang P +15 more
europepmc +1 more source
Latent TB infection in solid organ transplant recipients in Serbia: A single center experience from a low TB burden country. [PDF]
Milisavljevic J +3 more
europepmc +1 more source

